Literature DB >> 27878780

A pilot study using lactulose in management of minimal hepatic encephalopathy in children with extrahepatic portal vein obstruction.

Hanaa Mostafa El-Karaksy1,2, Omneya Afifi3, Azza Bakry4, Ann Abdel Kader5, Noha Saber4.   

Abstract

BACKGROUND: Minimal hepatic encephalopathy (MHE) is not associated with overt neuropsychiatric symptoms but rather with subtle changes in psychometric and/or neurophysiologic tests. We aimed to diagnose MHE in children with extrahepatic portal vein obstruction (EHPVO) and to evaluate the effect of lactulose on MHE.
METHODS: A prospective study was carried out on 30 patients with EHPVO (21 males; mean age 10±2.5 years). The study was carried out in the Pediatric Hepatology Unit, Cairo University Pediatric Hospital, Cairo, Egypt, between 2011 and 2013. All patients were subjected to clinical and laboratory assessment, neuropsychmetric testing using the arabic version of Wechsler intelligence tests, neurophysiological testing by visual electroencephalogram and P300 event related potentials (ERP).
RESULTS: The prevalence of MHE among children with EHPVO was 20% (6/30). After randomization to treatment and no-treatment groups using lactulose, all tests were repeated after three months. Among four patients with MHE who received lactulose, three (75%) improved. On the other hand, one of the patients in the no-treatment group developed MHE. Only one patient in the treatment arm had to discontinue lactulose because of severe diarrhea.
CONCLUSIONS: This pilot study revealed that the prevalence of MHE was 20%. Improvement on psychometic tests was seen in 75% of our patients (3/4) after treatment with lactulose. Lactulose treatment was well tolerated.

Entities:  

Keywords:  P300 event-related potential; children; extrahepatic portal vein obstruction; lactulose; minimal hepatic encephalopathy; neuropsychometric tests

Mesh:

Substances:

Year:  2016        PMID: 27878780     DOI: 10.1007/s12519-016-0066-2

Source DB:  PubMed          Journal:  World J Pediatr            Impact factor:   2.764


  33 in total

1.  Efficacy of lactulose in cirrhotic patients with subclinical hepatic encephalopathy.

Authors:  R K Dhiman; M S Sawhney; Y K Chawla; G Das; S Ram; J B Dilawari
Journal:  Dig Dis Sci       Date:  2000-08       Impact factor: 3.199

2.  Prevalence and natural history of subclinical hepatic encephalopathy in cirrhosis.

Authors:  A Das; R K Dhiman; V A Saraswat; M Verma; S R Naik
Journal:  J Gastroenterol Hepatol       Date:  2001-05       Impact factor: 4.029

Review 3.  Extrahepatic portal vein obstruction.

Authors:  Shiv K Sarin; Shri Ram Agarwal
Journal:  Semin Liver Dis       Date:  2002-02       Impact factor: 6.115

4.  Extrahepatic portal vein obstruction in Egyptian children.

Authors:  Hanaa M El-Karaksy; Nehal El-Koofy; Nabil Mohsen; Heba Helmy; Nevian Nabil; Mortada El-Shabrawi
Journal:  J Pediatr Gastroenterol Nutr       Date:  2015-01       Impact factor: 2.839

5.  Gastrointestinal bleeding in children.

Authors:  S K Yachha; A Khanduri; B C Sharma; M Kumar
Journal:  J Gastroenterol Hepatol       Date:  1996-10       Impact factor: 4.029

6.  Hepatic encephalopathy--definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998.

Authors:  Peter Ferenci; Alan Lockwood; Kevin Mullen; Ralph Tarter; Karin Weissenborn; Andres T Blei
Journal:  Hepatology       Date:  2002-03       Impact factor: 17.425

7.  Aetiology and management of extrahepatic portal vein obstruction in children: King's College Hospital experience.

Authors:  Nehal Abd El-Hamid; Rachel M Taylor; Daniela Marinello; G J Mufti; Raj Patel; Giorgina Mieli-Vergani; Mark Davenport; Anil Dhawan
Journal:  J Pediatr Gastroenterol Nutr       Date:  2008-11       Impact factor: 2.839

8.  Noncirrhotic portal vein thrombosis exhibits neuropsychological and MR changes consistent with minimal hepatic encephalopathy.

Authors:  Beatriz Mínguez; Juan Carlos García-Pagán; Jaume Bosch; Juan Turnes; Juli Alonso; Alex Rovira; Juan Córdoba
Journal:  Hepatology       Date:  2006-04       Impact factor: 17.425

Review 9.  Neuropsychological assessment of hepatic encephalopathy: ISHEN practice guidelines.

Authors:  Christopher Randolph; Robin Hilsabeck; Ainobu Kato; Parampreet Kharbanda; Yu-Yuan Li; Daniela Mapelli; Lisa D Ravdin; Manuel Romero-Gomez; Andrea Stracciari; Karin Weissenborn
Journal:  Liver Int       Date:  2009-03-19       Impact factor: 5.828

10.  Hepatic dysfunction in patients with extrahepatic portal venous obstruction.

Authors:  M Rangari; R Gupta; M Jain; V Malhotra; S K Sarin
Journal:  Liver Int       Date:  2003-12       Impact factor: 5.828

View more
  2 in total

Review 1.  Cognition-tracking-based strategies for diagnosis and treatment of minimal hepatic encephalopathy.

Authors:  Weijia Han; Huanqian Zhang; Ying Han; Zhongping Duan
Journal:  Metab Brain Dis       Date:  2020-06-03       Impact factor: 3.584

Review 2.  Cognitive Impairement in Non-Cirrhotic Portal Hypertension: Highlights on Physiopathology, Diagnosis and Management.

Authors:  Stefania Gioia; Silvia Nardelli; Oliviero Riggio; Jessica Faccioli; Lorenzo Ridola
Journal:  J Clin Med       Date:  2021-12-25       Impact factor: 4.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.